Delivery Order SPE2DB24D2205-SPE2DB25FEGLH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 18, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. OFEV (nintedanib) is a specialty pharmaceutical used in the treatment of pulmonary fibrosis...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on August 15, 2025, with completion targeted for September 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. OFEV (nintedanib) is a prescription medication used to treat idiopathic pulmonary fibrosis...
- The Defense Logistics Agency awarded a delivery order valued at $8.6K to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60 count) on August 12, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. OFEV (nintedanib) is a tyrosine kinase inhibitor primarily used to treat idiopathic pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- The Defense Logistics Agency awarded a $8,630.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OFEV (nintedanib) 100 mg capsules (60-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of OFEV 100 mg capsules (60-count units) valued at $8,630.28. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of OFEV (nintedanib) 150 mg capsules in a quantity of 60 units, with a ceiling value of $8,590.58. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award to the prime contractor. The order is scheduled for completion by August 11, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $7,643.51 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg capsules of OFEV to treat idiopathic pulmonary fibrosis. Amerisourcebergen will deliver 60 capsules to a facility in Conshohocken, Pennsylvania under a contract starting on September 21, 2023 and ending on October 13, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for OFEV capsules supports the DLA's...
- The Defense Logistics Agency awarded a $8,630.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OFEV (pirfenidone) 100 mg capsules (60-count unit) on July 21, 2025. The contract, which is expected to be completed by August 11, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGLHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of OFEV (nintedanib) 100 mg capsules in quantities of 60 units, with a contract ceiling value of $8,630.28. This is a firm fixed-price delivery order with no set-aside designation, issued under open competition. The ultimate completion date is September 9, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. OFEV is a prescription medication commonly used in the treatment of idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lung diseases, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products for military healthcare systems. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's successful competitive positioning and extensive federal contract portfolio demonstrate its capability as a critical vendor for the Department of Defense's medical supply chain and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 8/18/25 |